Literature DB >> 19793825

Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway.

Min Liang1, Kouki Morizono, Nonia Pariente, Masakazu Kamata, Benhur Lee, Irvin S Y Chen.   

Abstract

We recently developed a novel targeting Sindbis virus envelope pseudotyped lentiviral vector, 2.2ZZ, which acquires specific transduction capacity by antibody conjugation and binding with specific antigens on the surface of targeted cells. Here we characterize the virological properties of this vector by examining its targeting to CD4 antigen. Our results show that entry is dependent on CD4 cell surface density and occurs via the clathrin-mediated endocytic pathway. These findings provide insight into the mechanism of infection by a new viral vector with combined properties of Sindbis virus and lentiviruses and infectivity conferred by monoclonal antibody-ligand interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793825      PMCID: PMC2786851          DOI: 10.1128/JVI.01530-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Antibody-directed targeting of retroviral vectors via cell surface antigens.

Authors:  K Morizono; G Bristol; Y M Xie ; S K Kung; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120.

Authors:  M Merkenschlager; D Buck; P C Beverley; Q J Sattentau
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

3.  Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus.

Authors:  B O'Hara; S V Johann; H P Klinger; D G Blair; H Rubinson; K J Dunn; P Sass; S M Vitek; T Robins
Journal:  Cell Growth Differ       Date:  1990-03

4.  Entry of poliovirus into cells does not require a low-pH step.

Authors:  L Pérez; L Carrasco
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

6.  pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.

Authors:  B S Stein; S D Gowda; J D Lifson; R C Penhallow; K G Bensch; E G Engleman
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

7.  Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.

Authors:  P Bedinger; A Moriarty; R C von Borstel; N J Donovan; K S Steimer; D R Littman
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

8.  A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.

Authors:  Samantha H Johnston; Michael A Lobritz; Sandra Nguyen; Kara Lassen; Shirley Delair; Filippo Posta; Yvonne J Bryson; Eric J Arts; Tom Chou; Benhur Lee
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

9.  Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells.

Authors:  A Pelchen-Matthews; J E Armes; M Marsh
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.

Authors:  H Damke; T Baba; D E Warnock; S L Schmid
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  12 in total

Review 1.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

2.  Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.

Authors:  Kouki Morizono; Amy Ku; Yiming Xie; Airi Harui; Sam K P Kung; Michael D Roth; Benhur Lee; Irvin S Y Chen
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

3.  Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells.

Authors:  Saliha Majdoul; Jeremie Cosette; Ababacar K Seye; Eric Bernard; Sophie Frin; Nathalie Holic; Nathalie Chazal; Laurence Briant; Lucile Espert; Anne Galy; David Fenard
Journal:  J Biol Chem       Date:  2017-09-19       Impact factor: 5.157

Review 4.  Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms.

Authors:  Alexander Michels; Naphang Ho; Christian J Buchholz
Journal:  Mol Ther       Date:  2022-05-20       Impact factor: 12.910

5.  Retargeting vesicular stomatitis virus glycoprotein pseudotyped lentiviral vectors with enhanced stability by in situ synthesized polymer shell.

Authors:  Min Liang; Ming Yan; Yunfeng Lu; Irvin S Y Chen
Journal:  Hum Gene Ther Methods       Date:  2013-02       Impact factor: 2.396

6.  Versatile targeting system for lentiviral vectors involving biotinylated targeting molecules.

Authors:  Kathy Situ; Bernadette Anne Chua; Song Yi Bae; Aaron Samuel Meyer; Kouki Morizono
Journal:  Virology       Date:  2018-10-02       Impact factor: 3.616

7.  Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells.

Authors:  Saliha Majdoul; Ababacar K Seye; Antoine Kichler; Nathalie Holic; Anne Galy; Burkhard Bechinger; David Fenard
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

8.  R5 HIV env and vesicular stomatitis virus G protein cooperate to mediate fusion to naive CD4+ T Cells.

Authors:  Matthew J Pace; Luis Agosto; Una O'Doherty
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

9.  Genetic in vivo engineering of human T lymphocytes in mouse models.

Authors:  Tatjana Weidner; Shiwani Agarwal; Séverine Perian; Floriane Fusil; Gundula Braun; Jessica Hartmann; Els Verhoeyen; Christian J Buchholz
Journal:  Nat Protoc       Date:  2021-04-12       Impact factor: 13.491

10.  Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.

Authors:  Xian-Yang Zhang; Robert H Kutner; Agnieszka Bialkowska; Michael P Marino; William B Klimstra; Jakob Reiser
Journal:  Retrovirology       Date:  2010-01-25       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.